Overview
🌐 Website:
💲 Revenue:
📍 Address:
👥 Employees:
🗓️ Established: 2020
📅 Published: November 13, 2025
✏️ Last updated: July 13, 2026
EsoBiotec
AskAI Summary of EsoBiotec
Generated using ISVWorld's AskAI proprietary software industry model.
📝 AskAI Recap: EsoBiotec develops innovative cancer immunotherapies using proprietary vector technology to deliver off-the-shelf, scalable immune cell therapies for oncology and autoimmune diseases.
💬 Inclusion Rationale: EsoBiotec develops and aims to commercialize proprietary software-driven biotechnological platforms (ENaBL vector platform) to create and deliver cellular therapies, which qualifies as software products (biotech software/therapy delivery platforms). Their focus on off-the-shelf, scalable solutions involving advanced vector technology and cell engineering indicates product software development and commercialization, thus making them an ISV.